Syzygium cumini (L.) Skeels (Myrtaceae) against diabetes - 125 Years of research

Pharmazie

Volumn 63, Issue 2, 2008, Pages 91-101

  Helmstädter, Axel ^a,b,c  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Inst fur Geschichte der Pharmazie   (Germany)

^c ABDA Bundesvereinigung Deutscher Apothekerverbande   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ELLAGIC ACID; GALLIC ACID; GLUCOSE; GLUCOSE TRANSPORTER 4; POLYPHENOL DERIVATIVE; SYZYGIUM CUMINI EXTRACT; TANNIN DERIVATIVE;

CONSTIPATION; DEPRESSION; DIARRHEA; DRUG ISOLATION; DRUG MEGADOSE; DRUG RESEARCH; GASTROINTESTINAL SYMPTOM; HISTORY OF MEDICINE; HUMAN; INCREASED APPETITE; LD 50; MEDICAL RESEARCH; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHYTOCHEMISTRY; PHYTOTHERAPY; PLANT SEED; REVIEW; SEED KERNEL; SIDE EFFECT; STOMACH DISCOMFORT; URINE COLOR; WEIGHT GAIN;

ANIMALS; CLINICAL TRIALS AS TOPIC; EUGENIA; HISTORY, 20TH CENTURY; HISTORY, ANCIENT; HUMANS; HYPOGLYCEMIC AGENTS; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 39449116560     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2008.7335     Document Type: Review

References (118)

1. Achrekar A, Kaklij GS, Pote MS, Kelkar SM (1991) Hypoglycemic activity of Eugenia jambolana and Ficus bengalensis: mechanism of action. In vivo 5: 143-147.
2. Anandharajan R, Jaiganesh S, Shankemarayanan NP, Viswakarma RA, Balakrishnan A (2006) In vitro glucose uptake activity of Aegles marmelos and Syzygium cumini by activation of Glut-4, PI3 kinase and PPAR-gamma in L6 myotubes. Phytomedicine 13: 434-441.
3. Arayne MS, Sultana N, Mirza AZ, Zuberi MH, Siddiqui FA (2007) In vitro hypoglycaemic activity of methanolic extract of some indigenous plants. Pak J Pharm Sci 20: 268-273.
4. Atta-Ur-Rahman, Zaman K (1989) Medicinal plants with hypoglycemic activity. J Ethnopharmacol 26: 1-55.
5. Babu PS, Stanely Mainzen Prince P (2004) Antihyperglycaemic and antioxidant effect of hyponidd, an ayurvedic herbomineral formulation in streptozotocin-induced diabetic rats. J Pharm Pharmacol 56: 1435-1442.
6. Baily CJ, Day C (1989): Traditional plant medicines as treatments for diabetes. Diabetes Care 12: 553-564.
7. Bajpai M, Pande A, Tewari SK, Prakash D (2005) Phenolic compounds and antioxidant activity of some food and medicinal plants. Int J Food Sci Nutr 56: 287-291.
8. Balfour TAE (1889) Report on the therapeutics and chemistry of jambul seed. New Commercial Plants and Drugs 11: 26-34.
9. Bansal R, Ahmad N, Kidwai JR (1981) Effects of oral administration of Eugenia jambolana seeds & chlorpropamide on blood glucose level & pancreatic cathepsin B in rat. Indian J Biochem Biophys 18: 377.
10. Basu BD (1918) Indian Medicinal Plants. Allahabad.
11. Benner R (1892) Ueber die Wirkung des Syzygium Jambolanum bei Diabetes mellitus. PhD thesis, Univ. Zürich.
12. Bhaskaran Nair R, Santhakumari G (1986) Anti-diabetic activity of the seed kernel of Syzygium cumini Linn. Ancient Sci Life 6: 80-84.
13. Bhatia IS, Bajaj KL, Ghangas GS (1971) Tannins in black plum seeds. Phytochemistry 10: 219-220.
14. Bhatia IS, Bajaj KL (1972) Tannins in black-plum (Syzygium cumini L.) seeds. Biochem J 128: 56.
15. Bhatia IS, Bajaj KL (1975) Chemical composition of the seeds and bark of Syzygium cumini. Planta Med 28: 346-352.
16. Birch R (1888) Jambul in diabetes. Brit Med J 20: 112-113.
17. Bnouham M, Ziyyat A, Mekhfi H, Tahri A, Legssyer A (2006) Medicinal plants with potential antidiabetic activity - a review of ten years of herbal medicine research (1990-2000). Int J Diabetes Metabol 14: 1-25.
18. Boersch R (1899) Verfahren zur Gewinnung eines Mittels gegen Diabetes aus Syzygium Jambolana und dessen Abarten. Deutsches Reichspatent 119864, 21.6.1899.
19. Brahmachari HD, Augusti KT (1961) Hypoglycemic agents from Indian indigenous plants. J Pharm Pharmacol 13: 381-182.
20. Burger A, Wachter H (1998) (ed) Hunnius: Pharmazeutisches Wörterbuch, 8. ed., p. 1339.
21. Chirvan-Nia MM, Ratsimamanga AR (1972) Régression de la cataracte et de l'hyperglycénie chez le Rat de sable (Psammomys obesus) diabétique ayant recu un extrait de Eugenia Jambolana (Lamarck) C R Acad. Sci Hebd Seances Acad Sci D 274: 1514-1516.
22. Christy T (1885) Syzygium Jambolanum. New Commercial Plants and Drugs 8 : 77-78.
23. Christy T (1887): Jambul. New commerical plants and drugs 10: 63-67.
24. Coates Cole JM (1888) Jambul in diabetes. Brit Med J 20: 901.
25. Colasanti G (1895) Ueber den antidiabetischen Werth des Syzygium Jambolanum. Therap Wschr 2: 776-781; 800-804; 815-822; 837-841; 856-865.
26. Elfahmi (2006) Phytochemical and biosynthetic studies of lignans with a focus on Indonesian medicinal plants. PhD thesis Univ. Groningen, p. 25.
27. Ellborne W (1888) Jambul. Pharm J Transact 921.
28. Fichtner (1889) Bericht über 3 Fälle von Diabetes. Dt Arch Klin Med 45: 112-124.
29. Gerlach W (1892) Zwei mit Syzygium Jambolanum behandelte Fälle von Diabetes mellitus. Therap Monatsh 6: 372-373.
30. Graeser C (1889) Experimentelle Untersuchungen über Syzygium Jambolanum gegen künstlichen Diabetes. Centralbl Klin Med 10: 481-485.
31. Graeser (1893) Studien und Erfahrungen über die Anwendung von Syzygium Jambulanum gegen Diabetes. Dtsch Med Wschr 19: 1001-1002.
32. Grover JK, Vats V, Rathi SS (2000) Anti-hyperglycemic effect of Eugenia jambolana and Tinospora cordifolia in experimental diabetes and their effects on key metabolic enzymes involved in carbohydrate metabolism. J Ethnopharmacol 73: 461-470.
33. Grover JK, Vats V, Rathi SS, Dawar R (2001) Traditional Indian anti-diabetic plants attenuate progression of renal damage in streptozotocin induced diabetic mice. J Ethnopharmacol 76: 233-238.
34. Grover JK, Yadav S, Vats V (2002a) Medicinal plants of India with antidiabetic potential. J Ethnopharmacol 81: 81-100.
35. Grover JK, Rathi SS, Vats V (2002b) Amelioration of experimental diabetic neuropathy and gastropathy in rats following oral administration of plant (Eugenia jambolana, Mucuna pruriens and Tinospora cordifolia) extracts. Indian J Exp Biol 40: 273-276.
36. Hart MC, Heyl FW (1916) Some constituents of jambul. J Am Chem Soc 38: 2805-2813.
37. Hartwich C (1897) Die Neuen Arzneidrogen aus dem Pflanzenreiche. Berlin, pp. 327-328.
38. Helmstädter A (2007) Antidiabetic drugs used in Europe prior to the discovery of insulin. Pharmazie 62: 717-720.
39. Henrichs H (1891) Ueber die Behandlung des Diabetes mellitus mit Syzygium Jambulanum [!]. PhD thesis, Univ. Giessen.
40. Hildebrandt H (1892) Zur Wirkungsweise des Syzygium Jambolanum beim Diabetes mellitus. Berl Klin Wschr 29: 5-7.
41. Ivorra MD, Payá M, Villar A (1989) A review of natural products and plants as potential antidiabetic drugs. J Ethnopharmacol 27: 248-275.
42. Johannson G (1891) Beiträge zur Pharmacognosie einiger, bis jetzt wenig bekannter Rinden. PhD thesis, Univ. Dorpat, p. 15.
43. Joshi CS, Priya ES, Venkataraman S (2007) Acute and subacute toxicity studies on the polyherbal antidiabetic formulation Diakyur in experimental animal models. J Health Sci 53: 245-249.
44. Kar A, Choudhary BK, Bandyopadhyay NG (2003) Comparative evaluation of hypoglycaemic activity of some Indian medicinal plants in alloxan diabetic rats. J Ethnopharmacol 84: 105-108.
45. Karthic K, Kirthiram KS, Sadasivam S, Palvannan T, Thayumanavan B: Identification of alpha-amylase inhibitors from Syzygium cumini Linn seeds. Indian J Exper Biol submitted.
46. Kaufmann E (1928) Insulinersatzmittel, VII. Mitteilung. Über die Wirkung des Jambulrindenextraktes. Zschr Ges Experim Med 62: 160-164.
47. Kedar P, Chakrabarti CH (1983) Effects of Jambolan seed treatment on blood sugar, lipids and urea in streptozotocin induced diabetes in rabbits. Ind J Physiol Pharmacol 27: 135-140.
48. Khan B, Arayne MS, Naz S, Mukhtar N (2005) Hypoglycemic activity of aqueous extract of some indigenous plants. Pak J Pharm Sci 18: 62-64.
49. Kohli KR, Singh RH (1993) A clinical trial of Jambu [!] (Eugenia jambolana) in non-insulin dependant [!] diabetes mellitus. J Res Ayurveda Siddha 13: 89-97.
50. Kopanski L, Schnelle G (1988) Isolation of bergenin from barks of Syzygium cumini. Planta Med 54: 572.
51. Kotowaroo MI, Mahomoodally MF, Gurib-Fakim A, Subratty AH (2006) Screening of traditional antidiabetic medicinal plants of Mauritius for possible alpha-amylase inhibitory effects in vitro. Phytother Res 20: 228-231.
52. Laboratoires Laroche Navarron (1967) Hypoglycemic medicament based on Syzygium jambolanum. Patent Appl FR 1967-91714, FR 6114 19680726. Chem Abstr 76 (1972) 158336.
53. Lenné (1892a) Zur Aetiologie und Therapie des Diabetes mellitus. Münch Med Wschr 39: 601-602.
54. Lenné (1892b) Erfahrungen über Jambul. Therap Monatsh 6: 305.
55. Lenné (1894) Beitrag zur Behandlung des Diabetes mellitus mit Extr. fluid. Syzyg. jambol. e Cort. Therap Monatsh 8: 205-206.
56. Lewaschew S (1891) Ueber die Behandlung des Diabetes mellitus mit Syzygium Jambolanum. Berl Klin Wschr 20: 199-200.
57. Mahomed G (1888) Jambul in glucosuria. The Practitioner 41: 416-417.
58. Mallick C, Mandai S, Barik B, Bhattacharya A, Ghosh D (2007): Protection of testicular dysfunctions by MTEC, a formulated herbal drug, in streptozotocin induced diabetic rat. Biol Pharm Bull 30: 84-90.
59. Martindale W, Westcott W (1901) The Extra Pharmacopoeia, 10. ed. London, pp. 313-314.
60. Mendes Soares JC, Teixeira de Costa S, Cecim M (2000) Niveis glicemicos e de colesterol em ratos con Diabetes Mellitus [!] aloxano induzido, tratados com infusao de Bauhinia candicans ou Syzygium Jambolanum. Ciencia Rural 30, No. 1.
61. Merck's Jahresberichte über Neuerungen auf den Gebieten der Pharmakotherapie und Pharmazie (1891/92) Darmstadt, p. 38-39.
62. Merck's Jahresberichte über Neuerungen auf den Gebieten der Pharmakotherapie und Pharmazie (1900) Darmstadt, p. 193.
63. Minkowski (1893) Untersuchungen über den Diabetes mellitus nach Exstirpation des Pankreas. Arch Exper Pathol Pharmakol 31: 85-189, see pp. 125, 133, 189.
64. Mukherjee PK, Saha K, Murugesan T, Mandai SC, Pal M, Saha BP (1998) Screening of anti-diarrhoeal profile of some plant extracts of a specific region in West Bengal. Indian J Ethnopharmacol 60: 85-89.
65. Mukherjee PK, Maiti K, Mukherjee K, Houghton PJ (2006) Leads from Indian medicinal plants with hypoglycemic potentials. J Ethnopharmacol 106: 1-28.
66. Mutalik S, Chetana M, Sulochana B, Devi PU, Udupa N (2005) Effect of Dianex, a herbal formulation on experimentally induced diabetes mellitus. Phytother Res 19: 409-415.
67. N.N. (1890) Pharm Centralhalle 11: 605-606.
68. N.N. (1899) Neue Arzneimittel XIV. Pharm Ztg 44: 574.
69. N.N. (1901) Darstellung eines Glykosides aus Syzygium Jambolana. Pharm Ztg 46: 414.
70. Nande CV, Kale PM, Wagh SY, Autakar DS, Vaidya AB (1981) Effect of Jambu [!] fruit pulp (Eugenia jambolana Lam.) on blood sugar levels in healthy volunteers and diabetics. J Res Ayurveda Siddha 4: 1-5.
71. Neuwinger HD: Pflanzen zur Behandlung von Diabetes mellitus in der afrikanischen traditionellen Medizin (2004) Zschr Phytother 25: 224-233.
72. Noorden C von (1895) Die Zuckerkrankheit und ihre Behandlung. Berlin, p. 136.
73. Oliveira AC, Endringer DC, Amorim LA, das Gracas L, Brandao M, Coelho MM (2002) Effect of the extracts and fractions of Baccharis trimera and Syzygium cumini on glycaemia of diabetic and non-diabetic mice. J Ethnopharmacol 102: 465-469.
74. Pandey M, Khan A (2002) Hypoglycaemic effect of defatted seeds and water soluble fibre from the seeds of Syzygium cumini (Linn.) skeels in alloxan diabetic rats. Indian J Exp Biol 40: 1178-1182.
75. Pepato MT, Folgado VB, Kettelhut IC, Brunetti IL (2001) Lack of antidiabetic effect of Eugenia jambolana leaf decoction on rat streptozotocin diabetes. Braz J Med Biol Res. 34: 389-395.
76. Pepato MT, Mori DM, Baviera AM, Harami JB, Vendramini RC, Brunetti IL (2005) Fruit of the jambolan tree (Eugenia jambolana Lam.) and experimental diabetes. J Ethnopharmacol 96: 43-48.
77. Posner C, Epenstein H (1891) Ueber die Wirkung des Syzygium jambolanum. Berl Klin Wschr 28: 942-944.
78. Posthumus DH (1896) Syzygium Jambolanum bij Diabetes Mellitus. PhD thesis, Univ. Amsterdam.
79. Power FB, Callan T (1912) Chemical examination of jambul seeds. Pharm J Pharmacist 88: 414-417.
80. Prince PS, Menon VP, Pari L (1998) Hypoglycemic activity of Syzigium cumini seeds: effect on lipid peroxidation in alloxan diabetic rats. J Ethnopharmacol 61: 1-7.
81. Prince PS, Kamalakkannan N, Menon VP (2004) Antidiabetic and antihyperlipidaemic effect of alcoholic Syzigium cumini seeds in alloxan induced diabetic albino rats. J Ethnopharmacol 91: 209-213.
82. Quirini A (1888) Jambul seed. Pharm Post 21: 312-313.
83. Rathi SS, Grover JK, Vikrant V, Biswas NR (2002) Prevention of experimental diabetic cataract by Indian Ayurvedic plant extracts. Phytother Res 16: 774-777.
84. Ratsimamanga AR, Lefournier-Contensou C, Bibal-Prot P (1972) Action comparative d'un principe retiré d'écores de Eugenia Jambolana avec le NN-diméthyl biguanide et le glybutamide sur l'hyperglycé mie provoquée du rat normal. C. R. Acad. Sci Hebd Seances Acad Sci D 275: 913-915.
85. Ratsimamanga AR, Loiseau A, Ratsimamanga-Urveg S, Bibal-Prot P (1973) Nouvelle contribution à l'étude de l'action d'un principe hypoglycémiant mis en évidence dans l'écorce jeune de Eugenia Jambolana (Myrtacées) sur l'hyperglycémie provoquée du lapin mormal et poursuite de sa purification. C. R. Acad. Sci Hebd Seances Acad Sci D 277: 2219-2222.
86. Ratsimamanga RA, Ratsimamanga SR, Rasoanaivo P, Leboul J, Provost J, Freisdorf D (1996) Mischungen ausgehend von Eugenia jambolana Lamarck Samen, Herstellung und Verwendung solcher Mischungen sowie einiger Inhaltsstoffe als Medikamente. EU Patent 0879 058 B1 (DE 697 05 108 T2), 6.2.1996.
87. Rau O, Wurglics M, Dingermann Th, Abdel-Tawab M, Schubert-Zsilavecz M (2006) Screening of herbal extracts for activation of the human peroxisome proliferator-activated receptor. Pharmazie 61: 952-956.
88. Ravi K, Sekar DS, Subramanian S (2004a) Hypoglycemic activity of inorganic constituents in Eugenia jambolana seed on streptozotocin-induced diabetes in rats. Biol Trace Elem Res 99: 145-155.
89. Ravi K, Sivagnanam K, Subramanian S (2004b) Anti-diabetic activity of Eugenia jambolana seed kernels on streptozotocin-induced diabetic rats. J Med Food 7: 187-191.
90. Ravi K, Ramachandran B, Subramanian S (2004c) Effect of Eugenia Jambolana seed kernel on antioxidant defense system in streptozotocin-induced diabetes in rats. Life Sci 75: 2717-2731.
91. Ravi K, Ramachandran B, Subramanian S (2004d) Protective effect of Eugenia jambolana seed kernel on tissue antioxidants in strepotozotocin-induced diabetic rats. Biol Pharm Bull 27: 1212-1217.
92. Sagrawat H, Mann AS, Kharya MD (2006) Pharmacological potential of Eugenia jambolana: a review. Pharmacogn Mag 2: 96-105.
93. Saundby R (1887) Jambul in diabetes; saccharine in diabetes. Lancet 65: 834.
94. Schadewaldt H (1972) Geschichte des Diabetes mellitus. Berlin, pp. 72-73.
95. Schossler DRC, Mazzanti CM, Almeida da Luz SC, Filappi A, Prestes D, Ferreira da Silveira A, Cecim M (2004) Syzygium cumini and the generation of insulin positive cells from the pancreatic duct. Braz J Veterin Res Anim Sci 41: 236-239.
96. Sepaha GC, Bose SN (1956) Clinical observations on the antidiabetic properties of Pterocarpus marsupium and Eugenia jambolana. J Indian Med Assoc 27: 388-391.
97. Sharma SB, Nasir A, Prabhu KM, Murthy PS, Dev G (2003) Hypoglycemic and hypolipidemic effect of an ethanolic extract of seeds of Eugenia jambolana in alloxan-induced diabetic rabbits. J Ethnopharmacol 85: 201-206.
98. Sharma SB, Nasir A, Prabhu KM, Murthy PS (2006) Antihyperglycemic effect of the fruit-pulp of Eugenia jambolana in experimental diabetes mellitus. J Ethnopharmacol 104: 367-373.
99. Shotri DS, Meena Kelkar VK, Desmsukh, Aiman R (1963) Investigations of the hypoglycaemic properties of Vinca rosea, Cassia auriculata and Eugenia jambolana. Indian J Med Res 51: 464-467.
100. Sigogneau-Jagodzinski M, Bibal-Prot P, Chanez M, Boiteau P, Ratsimamanga AR (1967a) Contribution à l'étude de l'activité hypoglycémiante et antidiabétique d'un principe extrait du Rotra de Madagascar (Eugenia Jambolana Lamarck). C R Acad Sci Hebd Seances Acad Sci D 264: 1119-1123.
101. Sigogneau-Jagodzinski M, Bibal-Prot P (1967b) Contribution à l'étude de l'action d'un principe extrait du Rotra de Madagascar (eugenia Jambolana, Myrtacées) sur la glycémie du Rat normal. C R Acad Sci Hebd Seances Acad Sci D 264: 1223-1226.
102. Sigogneau-Jagodzinski M, Bibal-Prot P (1968) Etude modifications métaboliques induites par des extraits du Rotra de Madagascar (Eugenia jambolana Myrtacées Lamarck) sur le Rat et la Souris. C R Acad Sci Hebd Seances Acad Sci D 266: 1514-1516.
103. Sridhar SB, Sheetal UD, Pai MR, Shastri MS (2005) Preclinical evaluation of the antidiabetic effect of Eugenia jambolana seed powder in streptozotocin-diabetic rats. Braz J Med Biol Res 38: 463-468.
104. Srivastava Y, Venkatarishna-Bhatt H, Gupta OP, Gupta PS (1983) Hypoglycemia induced by Syzygium cumini Linn. seeds in diabetes mellitus. Asian Med J 26: 489-491.
105. Stanely Mainzen Prince P, Kamalakkannan N, Menon VP (2003) Syzygium cumini seeds reduce tissue damage in diabetic rat brain. J Ethnopharnacol 84: 205-209.
106. Steinmetz EF (1960) A botanical drug from the tropics used in the treatment of diabetes mellitus. Acta Phytother 7: 23-25.
107. Teixeira CC, Pinto LP, Kessler FH, Knijink L, Pinto CP, Gastaldo GJ, Fuchs FD (1997) The effect of Syzygium cumini (L.) skeels on postprandial blood glucose levels in non-diabetic rats and rats with streptozotocin-induced diabetes mellitus. J Ethnopharmacol 56: 209-213.
108. Teixeira CC, Rava CA, Mailman da Silva P, Melchior R, Argenta R, Naselmi F, Almeida CR, Fuchs FD (2000) Absence of antihyperglycemic effect of jambolan in experimental clinical models. J Ethnopharmacol 71: 343-347.
109. Teixeira CC, Weinert LS, Barbosa DC, Ricken C, Esteves, JF, Fuchs FD (2004) Syzygium cumini (L.) Skeels in the treatment of type 2 diabetes. Diabetes Care 27: 3019-3020.
110. Teixeira CC, Fuchs FD (2006) The efficacy of herbal medicines in clinical models: the case of jambolan. J Ethnopharmacol 108: 16-19.
111. Teixeira CC, Fuchs FD, Weinert LS, Esteves J (2006) The efficacy of folk medicines in the management of type 2 diabetes mellitus: results of a randomized controlled trial of Syzygium cumini (L.) Skeels. J Clin Pharm Ther 31: 1-5.
112. Vikrant V, Grover JK, Tandon N, Rathi SS, Gupta N (2001) Treatment with extracts of Momordica charantia and Eugenia jambolana prevents hyperglycemia and hyperinsulinemia in fructose fed rats. J Ethnopharmacol 76: 139-143.
113. Villasenor IM, Lamadrid MR (2006) Comparative anti-hyperglycemic potentials of medicinal plants. J Ethnopharmacol 104: 129-131.
114. Villy V (1891) Essai sur la valeur thérapeutique du jambul (Eugenia jambolana) dans le traitement du diabète sucré. PhD thesis, Univ. Paris.
115. Vix (1893) Jambul bei Glykosurie. Therap Monatsh 7: 160-161.
116. Wastl H, Boericke GW, Foster WC (1947) Studies of effects of Syzygium jambolanum on alloxan-diabetic rats. Arch Int Pharmacodyn 75: 33-50.
117. Zareba G, Serradell N, Castaner R, Davies SL, Prous J, Mealy N (2005) Phytotherapies for diabetes. Drugs Future 30: 1253-1282.
118. Zörnig H (1911) Arzneidrogen, II. Teil. Leipzig, pp. 128-129; 535-536.